KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322 | -20.7% | 10,105 | 0.0% | 0.11% | -11.2% |
| Q2 2023 | $406 | -5.8% | 10,105 | 0.0% | 0.12% | -6.7% |
| Q1 2023 | $431 | -11.1% | 10,105 | 0.0% | 0.13% | -17.3% |
| Q4 2022 | $485 | -99.9% | 10,105 | 0.0% | 0.16% | +23.7% |
| Q3 2022 | $380,000 | +36.2% | 10,105 | 0.0% | 0.13% | +39.4% |
| Q2 2022 | $279,000 | -49.3% | 10,105 | 0.0% | 0.09% | -43.7% |
| Q1 2022 | $550,000 | -6.9% | 10,105 | 0.0% | 0.17% | +3.1% |
| Q4 2021 | $591,000 | +47.8% | 10,105 | 0.0% | 0.16% | +52.8% |
| Q3 2021 | $400,000 | -6.8% | 10,105 | 0.0% | 0.11% | -3.6% |
| Q2 2021 | $429,000 | – | 10,105 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |